vs
Side-by-side financial comparison of Dynatrace, Inc. (DT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Dynatrace, Inc. is the larger business by last-quarter revenue ($515.5M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). Dynatrace, Inc. runs the higher net margin — 7.8% vs 6.8%, a 0.9% gap on every dollar of revenue. On growth, Dynatrace, Inc. posted the faster year-over-year revenue change (18.2% vs -1.7%). Over the past eight quarters, Dynatrace, Inc.'s revenue compounded faster (16.3% CAGR vs -0.1%).
Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DT vs MD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $515.5M | $493.8M |
| Net Profit | $40.1M | $33.7M |
| Gross Margin | 81.4% | — |
| Operating Margin | 14.1% | 9.9% |
| Net Margin | 7.8% | 6.8% |
| Revenue YoY | 18.2% | -1.7% |
| Net Profit YoY | -88.9% | 10.5% |
| EPS (diluted) | $0.13 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $515.5M | $493.8M | ||
| Q3 25 | $493.8M | $492.9M | ||
| Q2 25 | $477.3M | $468.8M | ||
| Q1 25 | $445.2M | $458.4M | ||
| Q4 24 | $436.2M | $502.4M | ||
| Q3 24 | $418.1M | $511.2M | ||
| Q2 24 | $399.2M | $504.3M | ||
| Q1 24 | $380.8M | $495.1M |
| Q4 25 | $40.1M | $33.7M | ||
| Q3 25 | $57.2M | $71.7M | ||
| Q2 25 | $48.0M | $39.3M | ||
| Q1 25 | $39.3M | $20.7M | ||
| Q4 24 | $361.8M | $30.5M | ||
| Q3 24 | $44.0M | $19.4M | ||
| Q2 24 | $38.6M | $-153.0M | ||
| Q1 24 | $37.9M | $4.0M |
| Q4 25 | 81.4% | — | ||
| Q3 25 | 81.8% | — | ||
| Q2 25 | 82.1% | — | ||
| Q1 25 | 80.9% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 81.4% | — | ||
| Q2 24 | 81.3% | — | ||
| Q1 24 | 81.1% | — |
| Q4 25 | 14.1% | 9.9% | ||
| Q3 25 | 14.8% | 13.8% | ||
| Q2 25 | 13.1% | 12.8% | ||
| Q1 25 | 9.6% | 7.0% | ||
| Q4 24 | 10.9% | 7.8% | ||
| Q3 24 | 11.2% | 6.6% | ||
| Q2 24 | 10.5% | -31.3% | ||
| Q1 24 | 6.1% | 3.2% |
| Q4 25 | 7.8% | 6.8% | ||
| Q3 25 | 11.6% | 14.5% | ||
| Q2 25 | 10.0% | 8.4% | ||
| Q1 25 | 8.8% | 4.5% | ||
| Q4 24 | 82.9% | 6.1% | ||
| Q3 24 | 10.5% | 3.8% | ||
| Q2 24 | 9.7% | -30.3% | ||
| Q1 24 | 10.0% | 0.8% |
| Q4 25 | $0.13 | $0.40 | ||
| Q3 25 | $0.19 | $0.84 | ||
| Q2 25 | $0.16 | $0.46 | ||
| Q1 25 | $0.12 | $0.24 | ||
| Q4 24 | $1.19 | $0.37 | ||
| Q3 24 | $0.15 | $0.23 | ||
| Q2 24 | $0.13 | $-1.84 | ||
| Q1 24 | $0.13 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $2.7B | $865.9M |
| Total Assets | $4.1B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.2B | $375.2M | ||
| Q3 25 | $1.3B | $340.1M | ||
| Q2 25 | $1.3B | $224.7M | ||
| Q1 25 | $1.1B | $99.0M | ||
| Q4 24 | $1.0B | $229.9M | ||
| Q3 24 | $1.0B | $103.8M | ||
| Q2 24 | $1.0B | $19.4M | ||
| Q1 24 | $836.9M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.7B | $865.9M | ||
| Q3 25 | $2.8B | $890.7M | ||
| Q2 25 | $2.7B | $833.8M | ||
| Q1 25 | $2.6B | $789.2M | ||
| Q4 24 | $2.6B | $764.9M | ||
| Q3 24 | $2.1B | $732.5M | ||
| Q2 24 | $2.1B | $706.5M | ||
| Q1 24 | $2.0B | $856.2M |
| Q4 25 | $4.1B | $2.2B | ||
| Q3 25 | $4.1B | $2.2B | ||
| Q2 25 | $4.1B | $2.1B | ||
| Q1 25 | $4.1B | $2.0B | ||
| Q4 24 | $3.7B | $2.2B | ||
| Q3 24 | $3.3B | $2.1B | ||
| Q2 24 | $3.3B | $2.0B | ||
| Q1 24 | $3.4B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | $114.1M |
| Free Cash FlowOCF − Capex | $27.2M | — |
| FCF MarginFCF / Revenue | 5.3% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 0.84× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $465.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $33.8M | $114.1M | ||
| Q3 25 | $32.0M | $137.3M | ||
| Q2 25 | $269.7M | $137.2M | ||
| Q1 25 | $162.8M | $-117.5M | ||
| Q4 24 | $42.2M | $133.0M | ||
| Q3 24 | $23.6M | $91.8M | ||
| Q2 24 | $230.7M | $107.0M | ||
| Q1 24 | $131.7M | $-125.2M |
| Q4 25 | $27.2M | — | ||
| Q3 25 | $27.8M | — | ||
| Q2 25 | $262.2M | — | ||
| Q1 25 | $148.2M | — | ||
| Q4 24 | $37.6M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $227.4M | — | ||
| Q1 24 | $121.9M | — |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 54.9% | — | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 57.0% | — | ||
| Q1 24 | 32.0% | — |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | 0.84× | 3.39× | ||
| Q3 25 | 0.56× | 1.91× | ||
| Q2 25 | 5.62× | 3.49× | ||
| Q1 25 | 4.14× | -5.66× | ||
| Q4 24 | 0.12× | 4.36× | ||
| Q3 24 | 0.54× | 4.72× | ||
| Q2 24 | 5.97× | — | ||
| Q1 24 | 3.47× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DT
| Subscription And Circulation | $493.4M | 96% |
| Services | $22.1M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
